Promoter hypermethylation mediated by DNA methyltransferases (DNMTs) is the main reason for epigenetic inactivation of tumor suppressor genes (TSGs). Previous studies showed that DNMT1 and DNMT3B play an important role in CpG island methylation in tumorigenesis. Little is known about the role of DNMT3A in this process, especially in hepatocellular carcinoma (HCC). In the present study, increased DNMT3A expression in 3 out of 6 HCC cell lines and 16/25 (64%) HCC tissues implied that DNMT3A is involved in hepatocellular carcinogenesis. Depletion of DNMT3A in HCC cell line SMMC-7721 inhibited cell proliferation and decreased the colony formation (about 65%). Microarray data revealed that 153 genes were upregulated in DNMT3A knockdown cells and that almost 71% (109/153) of them contain CpG islands in their 5 region. 13 of them including PTEN, a crucial tumor suppressor gene in HCC, are genes involved in cell cycle and cell proliferation. Demethylation of PTEN promoter was observed in DNMT3A-depleted cells implying that DNMT3A silenced PTEN via DNA methylation. These results provide insights into the mechanisms of DNMT3A to regulate TSGs by an epigenetic approach in HCC.
Introduction
Aberrant methylation of tumor suppressor genes (TSGs), which result in their silencing, is a common phenomenon in tumorigenesis [1, 2] . DNA methyltransferases (DNMTs) DNMT1, DNMT3A, and DNMT3B have been identified as functional DNA methylation enzymes in eukaryotic cells [3, 4] . DNMT3A and DNMT3B function as de novo methyltransferases that are responsible for de novo methylation, whereas DNMT1 functions as a maintenance enzyme for retaining methylation patterns. CpG islands residing within the promoter or the 5 end of genes are normally unmethylated in normal cells, and abnormal methylation of these CpG islands can efficiently repress transcription of the associated gene [5] . Silencing of TSGs by epigenetic alterations at promoter CpG islands is a common event found in many types of human cancers, including hepatocellular carcinoma (HCC). Overexpression of DNMTs has been reported in numerous studies on various malignancies including prostate, colorectal, and breast tumors. These findings suggest that DNMTs may contribute to tumorigenesis through epigenetic silencing of genes [6] [7] [8] [9] [10] [11] . The targeting of individual DNMTs to a gene is believed to play a critical role in determining its state of methylation. RNA interferencemediated knockdown or specific inhibition by antisense oligo-nucleotides of DNMT1 resulted in the reduction of promoter methylation in TSGs, such as RASSF1A, p16INK4a, and CDH1 [12, 13] . Satellite DNA is the target of methylation by DNMT3B. Interestingly, DNMT3B is also responsible for immunodeficiency, centromere instability, and facial anomalies (ICF) syndrome [14, 15] . Moreover, recent studies have shown that DNMT3B expression contributes to a CpG island methylator phenotype and that it epigenetically silences CXCL12 [16] , RECK [17] , and RASSF1A [18] through DNMT3B-mediated promoter methylation.
The function of DNMT3A is obscure and has not been associated with disease. DNMT3A is ubiquitously overexpressed in various types of tumors [19] [20] [21] [22] implying that it may be involved in and play an important role in tumorigenesis. However, very little is known about DNMT3A's ability to regulate gene expression, especially in regulating tumor suppressor genes. Recent results showed that DNMT3A expression mediates the repression of SFRP5 [23] and plakoglobin transcription [24] by direct hypermethylation of their promoter, indicating that DNMT3A's methylation activities are gene specific. However, the target genes of DNMT3A remain unknown. In this study, we attempted to identify tumor-related genes that are potentially regulated by DNMT3A and further discuss the prospect of gene expression regulation by DNMT3A. In this report, we also investigated the role of DNMT3A in the aberrant methylation and inactivation of genes in human tumor cells as well as its role in the maintenance of the transformed phenotype. . Synthesized 64nt siRNA template oligonucleotides were constructed into BglII and HindIII (TAKARA) sites of pSUPER-EGFP (gift from Professor Dianqing Wu at UCHC, USA), which has a green fluorescent protein marker and resistance to the G418, and named as pMT3A. The scramble sequences of DNMT3A siRNA were used as control and inserted into pSUPER-EGFP to form sMT3A. SMMC-7721 cells were transfected with recombinant plasmids using Lipofectamine 2000 according to the manufacturer's protocols (Invitrogen Corp., Carlsbad, CA) and were selected with medium containing 200 mg/mL G418 (Gibco, Grand Island, NY) for 2 months after the initial transfection. The cells stably harboring the targeting vector were monitored with green fluorescent protein (GFP) expression. SMMC-7721 cells were transfected with pMT3A and labeled as 7721-pMT3A cell lines; these were transfected with sMT3A and were designated as 7721-sMT3A cell lines or control.
Materials and Methods

HCC Cell Lines
Western Blot
Analysis. Cells (5 × 10 6 ) were harvested and the total proteins were prepared. Cell precipitate was resuspedded in 200 ul ice-cold lysis buffer (10 mmol/L Tris-Hcl (pH 8.0), containing 150 mmol/L NaCl, 1 mmol/L phenylmethylsulfonyl fluoride, and 1% Triton X-100). An equal amount of cellular proteins was loaded on 7% polyacrylamide gels (PAGE) in a 1×SDS-PAGE buffer (1 g/L SDS, 3 g/L Tris-base, and 14.4 g/L glycine). Proteins were transferred to a polyvinylpyrrolidine difluoride membrane electrophoretically and incubated overnight at 4 in block buffer (5% nonfat milk in Tris-Base Tween-20 (TBST). Membranes were incubated for 1 hour at room temperature with DNMT3A-specific monoclonal antibodies (1 : 5000, Imagenex) followed by six five-minute washes with TBST. After washing, the membrane was incubated with antimouse horseradish peroxidase-conjugated secondary antibodies (1 : 80000, Sigma), and the immune complexes were detected with enhanced chemiluminescence (Pierce). The membranes were probed with an antiactin antibody (Biomedical Technologies, Stoughton, MA) to confirm equal loading of each protein samples. β-actin protein levels were used as a control to ensure equal protein loading (β-actin, 1 : 8000, Sigma). Each experiment was repeated at least 3 times. The intensity ratios of the 2 bands from the same sample were determined and calculated by Gel-Pro Analyzer 3.0.
Microarray Hybridizations and Induced Genes Analysis.
Affymetrix Human Genome U133A 2.0 Array (Affymetrix, Santa Clara, CA), encompassing 18,400 transcripts and variants, including 14,500 well-characterized human genes on one array was processed. Microarray hybridization was performed in the SBC (Shanghai, China) using standard affymetrix procedures. Raw microarray data were acquired using GCOS1.2 software of affymetrix. The data were preprocessed using robust multiarray analysis (RMA) with a log base 2 (log2) transformation. Genes identified as differentially expressed genes, which is exhibiting, upregulated more than 2-fold to the control. Gene ontology of the differentially expressed genes was performed through the GO Mining Tool (http://www.affymetrix.com/ analysis/query/go analysis.affx). The potential promoter regions spanning 2000 bp upstream and 5'UTR around the transcription start site of 153 upregulated genes. Subsequently, CpG islands were identified within the core promoter region by CpG Island Searcher program (http://www.methdb.de/) in DNA Methylation Database (http://www.uscnorris.com/cpgisland2).
Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Real-Time Quantitative RT-PCR (qPCR) Analysis.
Total RNA was isolated using TRIzol reagent (Invitrogen, NY). cDNA was synthesized from 1 μg of total RNA using Oligo(dT) 18 as primers and reverse transcriptase following reverse-transcribed with Reverse Transcription System (Promega,) according to the kit's instructions. The expression levels of differentially expressed genes of microarray after DNMT3A RNAi were quantified using qRT-PCR analysis. PCR reactions containing 10 ng cDNA, SYBR green (1 : 20,000 dilutions) were included in each reaction to allow quantification of RNA levels using the ABI 7300 detection system (Applied Biosystems). To normalize the input load of cDNA among samples, either β-actin was quantified and used as an endogenous standard. The relative levels of expression of each target genes among different samples were calculated accordingly (ABI PRISM 7300 Detection System, USA). The conditions and primers designed for detected genes were listed in Table 1 . Each duplex PCR was repeated with at least 3 different cDNA preparations and 2 independent qPCR reactions for each cDNA.
Methylation-Specific PCR (MSP), Bisulfite Sequencing, and Treatment of 5-aza-dC.
Genomic DNA was extracted according to standard method [25] . Bisulfite treatment was performed by the Methylamp DNA Modification Kit (Epigentek) following the manufacturer's instruction. Modified DNA was amplified to determine the methylation status of the promoter region of gene by MSP. The primer sequences and PCR conditions for amplification above were shown in Table 2 . PCR products for the bisulfite sequencing were gel-purified, subcloned into a pEASY-T3 vector system (TransGen Biotech). At least ten colonies were sequenced to assess the degree of methylation in each CpG site. For demethylation analysis, cells were plated and treated with 100 μmol/L 5-aza-dC (Sigma) for up to 4 days. The total RNA was extracted from exponentially growing cultures on the 3rd day after treatment.
Cell Proliferation and Colony Formation Assay.
Cell proliferation of transfected stable SMMC-7721 cells with construct pMT3A and its control sMT3A were measured by Cell Counting Kit-8 (CCK-8) (Dojindo Laboratories, Kumamoto, Japan). The absorbance at 450 nm was measured to represent the cell viability, which was measured to assess the cell proliferation of those cell lines. All experiments were independently repeated at least three times.
1 × 10 3 cells were suspended in 1.5 ml of 0.3%-melted agar in RPMI 1640 medium (Invitrogen, Carlsbad, CA. USA) with 5% FCS, and plated in a standard 6-well cell culture plate containing a solidified layer of 3 ml 0.6% agarose gel in the same medium. After 14 days of incubation at 37
• C in 5% CO 2 , colony growth in soft agar was assayed by visually counting the colonies. All evaluations were performed in a blinded manner. The experiments were independently performed three times.
Statistical
Analysis. Data were presented as means ± standard error (SE). Data were analyzed using Graphpad Prism 5 software (GraphPad Software, San Diego, CA). Mean difference was determined by Student t-tests. Statistical significant differences were defined as P < .05. Standard statistical tests were performed using SPSS (version 13.0).
Results
Increased Expression of DNMT3A in HCC Cell
Lines and HCC Tissues. The expression level of DNMT3A was measured in HCC cell lines by western blot and was normalized to β-actin. There was lower expressed DNMT3A in human normal liver cells (HL-7702) and differentially expressed in HCC cell lines (Figure 1(a) ). Increased expression of DNMT3A was found in 3 out of 6 HCC cell lines, especially in SMMC-7721 and BEL-7402. Specifically, there was a 6.1-and 5.8-fold increase in DNMT3A expression in SMMC-7721 and BEL-7402, compared to HL-7702, respectively. The mRNA expression level of the DNMT3A was detected by qPCR in tumor tissues and noncancerous liver tissues from 25 HCC patients. Increased expression of DNMT3A was detected in 16 out of 25 cases (64%) of HCCs (Figure 1(b) ). These data suggested that DNMT3A may play a role in the progression of HCC tumorigenesis, and this finding needs to be confirmed by a larger study.
DNMT3A siRNA Construct Suppresses DNMT3A Specifically and Stably in HCC Cell
Line. Knockdown of transcripts using siRNA is a powerful tool for studying gene function. We designed three target siRNAs (Figure 2(a) ), which can suppress all of the different DNMT3A transcripts, and one nonspecific scramble siRNA, which was used as control (see Table 1 in Supplementary Material available online at doi:10.1155/2010/737535). The candidate siRNA-2 effectively suppressed DNMT3A expression in levels of protein (P = .001) and encoding mRNA (P = .011) (Figures  2(b), 2(c), 2(d) ). No significant inhibition on DNMT1 and DNMT3B was detected in DNMT3A RNAi treatment cells (Figure 2(d) ). Expression of endogenous β-actin was used as a control to normalize the expression level of DNMT1, DNMT3A, and DNMT3B.
Depletion of DNMT3A Inhibits Cell Proliferation and Colony Formation in SMMC-7721 Cells.
To explore the functional consequences of DNMT3A depletion in HCC, we evaluated the role of DNMT3A-specific siRNA treatment on cell proliferation and colony formation in HCC cells. Transfected clones were picked up and expanded for an additional 2 months and analyzed for DNMT3A in protein levels. DNMT3A expression was stably suppressed in SMMC-7721 (Figure 3(a) ). Compared to control 7721-sMT3A cells, 7721-pMT3A formed significantly fewer colonies (about 65%) in soft agar assay (Figure 3(b) ) and with lower cell proliferation ability in CCK-8 cell assay (Figure 3(c) ).
Gene Expression Profiling
Induced by DNMT3A Knockdown. To elucidate the effects of increased DNMT3A expression in HCC tumorigenesis, Affymetrix HG U133A oligonucleotide microarray was used to evaluate induced gene expression profiling in DNMT3A depletion cells compared with control. The data revealed that 153 genes were upregulated in DNMT3A knockdown cell (Supplementary Table  2 ). These genes were categorized to numerous biological processes by using the GO Mining Tool [26] . All genes were combined into 17 superordinate categories (Figure 4) . Three categories contained the largest number of affected genes: molecular transport (26 genes), transcription regulation (14 genes), and cell cycle (13 genes). Since a CpG island (CGI) near the transcription initiation site is usually important changes observed on arrays were valid, quantitative real-time PCR was used to analyze several cancer-related genes and confirmed the data from the array.
Depletion of DNMT3A Induced PTEN via Demethylation of CpG Sites in Its Promoter
Region. In DNMT3A depletion cells, tumor suppressor gene PTEN was activated ( Figure 5(a) ). As 5-Aza-2 deoxycytidine, a demethylation agent could restore PTEN expression ( Figure 5(b) ); we supposed that activated PTEN in DNMT3A depletion cells is maybe involved in demethylation. To explore whether the repression of PTEN expression is due to DNA methylation; we examined the status of methylation of its promoter in DNMT3A depletion cells 7721-pMT3A and control by MSP method. The result showed that restoring of the PTEN was significantly associated with its promoter demethylation in the 7721-pMT3A cell line ( Figure (5(c)) ). Subsequently, a 331 bp (−1128/−798) fragment that contained part of the PTEN promoter and its 5 untranslated region (5 UTR) ( Figure 5(d) ) is chosen for further methyaltion analysis by bisulfite sequencing. Ten individual colonies were sequenced to identify methylated cytosine residues. We found that all six CpG sites were unmethylated in 7721-pMT3A. In contrast, different CpG sites (S1, S2, S4, or S6) were methylated in the 7721-sMT3A cell line. The results indicated that DNMT3A knockdown changed the methylation status of certain CpG sites within the 5 UTR and promoter of the PTEN gene. These data suggested that PTEN expression is regulated in a methylation-dependent manner and that PTEN may be preferentially methylated by DNMT3A.
Discussion
HCC is a severe disease with a very poor prognosis and is the fourth largest cause of cancer-related deaths worldwide [26, 28] . DNA hypermethylation of tumor suppressor genes is frequently observed in HCCs [25, [29] [30] [31] . The process of aberrant DNA methylation is catalyzed by DNA methyltransferases (DNMTs). Moreover, DNMTs expression is increased during early tumorigenesis. In hepatocarcinogenesis, increased expression of DNMTs mRNA is correlated with a progressive increase in the number of methylated genes from normal liver, chronic hepatitis/cirrhosis to HCC [32] . One hypothesis is that abnormal expression of the three functional DNMTs may be important in regulating tumor suppressor gene expression during hepatocellular tumorigenesis. DNMT1 and DNMT3B were both shown to be important for cancer cell survival and tumorigenesis [33] . However, the relationship between DNMT3A and tumorigenesis is still uncertain. Previous studies suggested that DNMT3A is developmentally regulated and was shown to be important in establishing maternal imprints in mice [34, 35] . Recently, researchers found that elevated DNMT3A activity promotes polyposis in Apc (Min) mice [23] and that knockdown of DNMT3A dramatically inhibits melanoma growth and metastasis in mouse melanoma models [36] . Several studies showed that increased expression of DNMT3A in HCC implied that DNMT3A was involved in hepatocarcinogenesis. In order to evaluate the effect of DNMT3A depletion, we examined the characteristics of SMMC-7721 cells in vitro, using proliferation and colony-forming. The results showed that cell proliferation and colony-forming ability did differ between the WT and DNMT3A-depleted SMMC-7721 cells. DNMT3A depletion produced primarily antiproliferative effects. These results were observed in another HCC cell line QSG-7701 (Supplementary). Microarray analysis revealed that inhibition of DNMT3A induced expression of various genes that are involved in cell cycle regulation, transcription regulation, and signal transduction and are thus implicated in the inhibition of HCC cell growth. Whether depletion of DNMT3A is capable of inhibiting the growth of hepatocellular carcinoma in vivo, mice malignant hepatocellular carcinoma models should be established in the further study.
Our previous studies showed that depleting DNMT1 and DNMT3B induced expression of different sets of TSGs in HCC cell lines [37, 38] . Here, DNMT3A depletion significantly altered the expression of tumor-related genes on the array. However, the regulation of these genes by DNMT3A-mediated methylation or other epigenetic mechanisms is unknown. In addition to analyzing the influence of DNMT3A depletion on the broad changes in gene expression by cDNA arrays, we sought to elucidate the potential mechanism by which DNMT3A may regulate TSGs. To this end, we began an analysis of CGI sites contained within the promoter regions of altered genes by using CpG Island Searcher. Almost 71% (109/153) of induced genes contain CpG islands in their 5 region, suggesting that DNA methylation plays an important role in the regulation of gene expression by DNMT3A. Compared with control, phosphatase and tensin homolog (PTEN), a tumor suppressor gene in HCC, is significantly induced by DNMT3A knockdown. PTEN is silenced by DNA methylation at high frequencies in HCC, and promoter methylation and silencing of PTEN is reported to be associated with HCC [39, 40] . One of the mechanisms of PTEN inactivation is epigenetic silencing, which has been reported in various tumors including hematologic malignancies and some solid tumors [41] [42] [43] [44] . In this study we found that PTEN can be restored due to demethylation of its promoter by demethylating agents in SMMC-7721 cells. PTEN is known for its essential role in regulating the PI3K/AKT signaling pathway [45] . PTEN loss leads to activation of AKT kinases, which contributes to cell survival, growth, proliferation, and invasion [46, 47] . The methylation of the PTEN promoter and its associated loss in activity is observed in HCC. These results demonstrate that depletion of DNMT3A affects cell proliferation and that this effect may be a result of the reexpression of the formerly silenced PTEN. In the present study, we found that DNMT3A may play a role in hepatocellular carcinogenesis by its role in regulating the expression of some tumor suppressor genes such as PTEN. However, it is necessary to further study additional DNMT3A mechanisms of regulation of TSGs and its function in tumorigenesis.
Conclusion
Our results provide evidence that DNMT3A depletion significantly inhibited cell growth and colony formation in HCC cells. The most likely mechanism for this inhibition of tumorigenesis includes the reactivation of epigenetically silenced tumor suppressor genes, such as the PTEN gene.
